SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on August 16, 2021. The filing serves to announce the Company's financial results for the three and six months ended June 30, 2021. The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Carlsbad, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
No specific material changes versus prior periods are quantified in this filing. The document solely references the issuance of a press release containing the comparative financial results.
Guidance, Outlook, and Risks
The filing includes standard legal disclaimers stating that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other SEC filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed in the text of this 8-K.
Investor Verification Checklist
- Verify the specific revenue and net loss figures in the attached Exhibit 99.1 (Press Release).
- Confirm the Company's cash position and burn rate as of June 30, 2021, from the referenced press release.
- Review the press release for any updates on product development milestones or regulatory approvals.
- Note that the registrant is Ra Medical Systems, Inc., not Catheter Precision, Inc.